Tumor Heterogeneity of FIGO Stage III Carcinoma of the Uterine Cervix

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 5, 2009, Pages 1323-1328

  Kim, Yong Bae ^a   Lee, Ik Jae ^a   Kim, Song Yih ^a   Kim, Jun Won ^a   Yoon, Hong In ^a   Kim, Sang Wun ^a   Kim, Sunghoon ^a   Kim, Young Tae ^a   Suh, Chang Ok ^a   Kim, Gwi Eon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

FIGO Stage III; Radiotherapy; Tumor heterogeneity; Uterine cervical cancer

Indexed keywords

COMPLETE RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FAILURE RATE; FIGO STAGE III; HETEROGENEOUS SUBGROUPS; HIGH-DOSE RATE BRACHYTHERAPY; HYDRONEPHROSIS; INTERNATIONAL FEDERATION; KAPLAN-MEIER METHOD; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL RATES; PATTERNS OF FAILURE; SURVIVAL RATE; TREATMENT POLICIES; TUMOR HETEROGENEITY; UTERINE CERVICAL CANCER; UTERINE CERVIX;

DECISION MAKING; FLUORINE CONTAINING POLYMERS; MULTIVARIANT ANALYSIS; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SURVEYS;

TUMORS;

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL HETEROGENEITY; CLINICAL EVALUATION; CONTINUOUS INFUSION; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; HYDRONEPHROSIS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 71649097907     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.081     Document Type: Article

References (15)

1. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
2. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
3. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
4. Odicino F., Pecorelli S., Zigliani L., et al. History of the FIGO cancer staging system. Int J Gynaecol Obstet 101 (2008) 205-210
5. Follen M., Levenback C.F., Iyer R.B., et al. Imaging in cervical cancer. Cancer 98 (2003) 2028-2038
6. Park T.K., Kim S.N., Kim S.W., et al. Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors. J Korean Med Sci 15 (2000) 436-441
7. Park T.K., Choi D.H., Kim S.N., et al. Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 41 (1991) 107-112
8. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. (2002), Springer, Chicago
9. Piver M.S., and Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46 (1975) 507-510
10. Fletcher G.H. Cancer of the uterine cervix. Janeway lecture, 1970. Am J Roentgenol Radium Ther Nucl Med 111 (1971) 225-242
11. Kovalic J.J., Perez C.A., Grigsby P.W., et al. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 21 (1991) 905-910
12. Barillot I., Horiot J.C., Pigneux J., et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French cooperative study: Update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 38 (1997) 969-978
13. Arthur D., Kaufman N., Schmidt-Ullrich R., et al. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys 31 (1995) 743-751
14. Hsu H.C., Leung S.W., Huang E.Y., et al. Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 40 (1998) 405-410
15. Chao K.S., Leung W.M., Grigsby P.W., et al. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer. Int J Radiat Oncol Biol Phys 40 (1998) 1095-1100